	Capitaux Propres Et Réserves		Date
Acadia Pharmaceuticals	USD 917.27M	94.89M	2025-09
Akebia Therapeutics	USD 41.59M	12.37M	2025-09
ALKERMES	USD 1.73B	108.85M	2025-09
Alnylam Pharmaceuticals	USD 789.18M	555.28M	2025-12
Amarin	USD 458.89M	6.03M	2025-09
ANI Pharmaceuticals	USD 505.82M	69.06M	2025-09
BioMarin Pharmaceutical	USD 6.06B	29.6M	2025-09
Coherus Biosciences	USD 87.77M	32.05M	2025-09
Emergent BioSolutions	USD 649.3M	47.9M	2023-12
Exact Sciences	USD 2.4B	100.37M	2025-12
Exelixis	USD 2.16B	619K	2025-12
Glaxosmithkline	GBP 21.7B	7.35B	2025-09
Heron Therapeutics	USD 14.88M	42.14M	2025-09
Ionis Pharmaceuticals	USD 617.97M	13.76M	2025-09
Ironwood Pharmaceuticals	USD -264.16M	44M	2025-09
Lexicon Pharmaceuticals	USD 129.44M	6.41M	2025-06
Lonza	CHF 9.33B	23M	2024-12
Merck	USD 51.85B	2.79B	2025-09
Moderna	USD 8.65B	680M	2025-12
Myriad Genetics	USD 372.8M	15.3M	2025-09
Nektar Therapeutics	USD 85.09M	109.3M	2025-09
Neurocrine Biosciences	USD 3.25B	249.5M	2025-12
Pacira	USD 727.21M	30.55M	2025-09
Pfizer	USD 92.8B	4.11B	2025-09
PTC Therapeutics	USD -155.76M	50.79M	2025-09
Sanofi	EUR 71.71B	1.55B	2025-12
Sarepta Therapeutics	USD 1.32B	37.26M	2025-09
United Therapeutics	USD 6.59B	583.4M	2025-09
Vanda Pharmaceuticals	USD 327.19M	138.81M	2025-12
Xoma	USD 87.94M	15.5M	2025-09

Emergent BioSolutions Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.